Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Toll-like Receptor 4 (TLR4)
68%
Monocytes
63%
Toll-like Receptor 2 (TLR2)
54%
Inflammasome Activation
50%
Primary Monocytes
50%
Kinase Activity
50%
NOD-like Receptor Protein 3 (NLRP3)
50%
Receptor-interacting Protein Kinase 1 (RIPK1)
50%
Interleukin-1β
50%
Convalescent COVID-19
50%
Retinoic Acid-inducible Gene I (RIG-I)
50%
Gene Expression
50%
Cytokine Expression
50%
COVID-19
50%
Steady State
50%
Gasdermin D (GSDMD)
22%
Alternative Pathway
22%
Toll-like
20%
Pyroptosis
18%
Innate Immune Receptors
14%
Trained Immunity
14%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
14%
Copyright
14%
Differentially Expressed Genes
14%
Inflammatory Response
14%
K+ Efflux
13%
Secondary Signal
9%
Mild Symptoms
7%
Antiviral Response
7%
Innate Immune Signaling Pathways
7%
Initial Infection
7%
DDX58
7%
Epigenetic Reprogramming
7%
Receptor 1
7%
Cytokine Secretion
7%
Metabolic Reprogramming
7%
Severe Symptoms
7%
Progenitor Cells
7%
Receptor Activation
7%
Reinfection
7%
Nave
7%
Unvaccinated
7%
Pharmacology, Toxicology and Pharmaceutical Science
Toll Like Receptor 4
100%
Receptor
71%
Toll Like Receptor 2
60%
Nucleotide Binding Oligomerization Domain Like Receptor
50%
Protein Kinases
50%
Pyrin
50%
Phosphotransferase
50%
Inflammasome
50%
Retinoic Acid
50%
SARS Coronavirus
50%
Cytokine
50%
Pyroptosis
40%
Effusion
30%
Potassium Ion
30%
Infection
21%
Toll Like Receptor
20%
Toll Like Receptor 1
17%
Inflammation
14%
Interferon
10%
Caspase 8
10%
Toll Like Receptor 8
10%
Adaptor Protein
10%
Interleukin 1beta Converting Enzyme
10%
Toll Like Receptor 7
10%
Reinfection
7%
Antivirus Agent
7%
Immunology and Microbiology
TLR4
50%
TLR2
50%
Steady State
50%
Gene Expression
50%
Cytokine
50%
Inflammasome
50%
COVID-19
50%
Severe Acute Respiratory Syndrome Coronavirus 2
50%
Immune System Receptors
14%
Inflammation Response
14%
Monocyte Response
7%
TLR 1
7%
Cytokine Release
7%
